SELL TO SCIENTISTS.

Industry Profile

Oncology Diagnostics

Target researchers — Molecular biologists and bioinformaticians in liquid biopsy, NGS, methylation analysis, and assay development

Oncology diagnostics develops blood-based and genomic tests to detect and monitor cancer earlier and more precisely. It recruits molecular biologists and bioinformaticians from academia and partners with cancer centers on biomarker and assay research.

$55B Market size
10 Key companies
5 Use cases

Key Companies

Grail Guardant Health Foundation Medicine Exact Sciences Natera Tempus Freenome Adaptive Biotechnologies Caris Life Sciences Delfi Diagnostics

Use Cases

01

Liquid-biopsy R&D recruitment

02

ctDNA-assay validation partnerships

03

University cancer-genomics collaborations

04

Bioinformatics talent pipeline

05

Early-detection clinical-study alliances

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started